Branded Medicine

 
IRGAPAN®

Film-coated tablet

 
:: COMPOSITIONS ::

IRGAPAN® 100
Each film-coated tablet contains:
Phenylbutazone 100 mg

IRGAPAN® 200
Each film-coated tablet contains:
Phenylbutazone 200 mg

 
:: INDICATIONS ::

Active ankylosing spondylitis, acute gouty arthritis, active rheumatoid arthritis, acute osteoarthritis.

 
:: CONTRAINDICATIONS ::
  • Patients with peptic ulcer, coagulation disorder, severe hypertension, thyroid disease, Sjögren syndrome.
  • Asthma patients.
  • Patients with cardiac, liver and renal dysfunction.
  • Patients with a known hypersensitivity.
 
:: DOSAGE AND ADMINISTRATIONS ::
  • Active rheumatoid arthritis, acute osteoarthritis and active ankylosing spondylitis:
    300-600 mg daily in 3-4 divided doses. Thereafter, the treatment is lowered to 200-300 mg daily in divided dose. The administration of medicine must be stopped if response does not appear.
  • Acute gouty arthritis:
    Initial dose 600-800 mg daily in 2-3 divided doses for 1-3 days. If necessary, the dose may be given 300-400 mg daily. The duration of treatment may not exceed 7 days.
  • Take medicine with meals or milk.
 
:: SPECIAL PRECAUTIONS ::
  • Patients with cardiovascular disorders.
  • Nursing mothers.
  • Not recommended for pregnant women, children less than 14 years old and patients 60 years old or more.
 
:: ADVERSE REACTIONS ::

Nausea, vomiting, epigastric pain, skin allergic reactions, stomach disorders, diarrhea, vertigo, insomnia, euphoria, hematuria, blurred vision, icterus, hepatitis, gastric ulceration and bleeding.

 
:: PRESENTATION ::

IRGAPAN® 100. Box,
10 strips @ 10 film-coated tablets.

IRGAPAN® 200. Box,
10 strips @ 10 film-coated tablets.

STORE AT TEMPERATURES BELOW 30oC,
PROTECT FROM LIGHT

Manufactured by:
PT Dexa Medica
Jl. Jenderal Bambang Utoyo 138
Palembang-Indonesia